Fayenceries de Sarreguemines, Digoin & Vitry-le-Francois Société Anonyme (EPA:FSDV)
16.10
0.00 (0.00%)
At close: Aug 1, 2025, 5:30 PM CET
Revance Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
231.83M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | - | - | - |
Mar 31, 2023 | - | - | - |
Mar 31, 2022 | - | - | - |
Mar 31, 2021 | - | - | - |
Mar 31, 2020 | - | - | - |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LVMH Moët Hennessy - Louis Vuitton, Société Européenne | 82.82B |
Hermès International Société en commandite par actions | 15.70B |
L'Oréal | 43.84B |
Airbus SE | 70.02B |
Schneider Electric S.E. | 39.32B |
Safran | 29.38B |
EssilorLuxottica Société anonyme | 27.24B |
TotalEnergies SE | 159.33B |